Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726599 | SCV000701734 | pathogenic | not provided | 2018-01-04 | criteria provided, single submitter | clinical testing | |
Clinical Molecular Genetics Laboratory, |
RCV000595095 | SCV000824711 | pathogenic | Becker muscular dystrophy | 2018-10-04 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000990560 | SCV001141572 | pathogenic | Duchenne muscular dystrophy | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000990560 | SCV001206134 | pathogenic | Duchenne muscular dystrophy | 2021-12-19 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu3485Profs*6) in the DMD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DMD are known to be pathogenic (PMID: 16770791, 25007885). This premature translational stop signal has been observed in individuals with Duchenne or Becker muscular dystrophy (PMID: 17041906, 21396098, 26911353, 29973226). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 497301). This variant is also known as c.10454dupC, c.10453_10454insC and c.10453insC. |
Laboratory of Medical Genetics, |
RCV000595095 | SCV002769665 | pathogenic | Becker muscular dystrophy | 2022-12-16 | criteria provided, single submitter | clinical testing | PVS1, PM2, PP5 |
Revvity Omics, |
RCV000726599 | SCV004234420 | pathogenic | not provided | 2023-07-11 | criteria provided, single submitter | clinical testing |